Global public health is in focus at #EASLCongress as EASL, WHO, and ECDC join forces for the symposium on Targeting viral hepatitis for HCC prevention. This session is addressing the urgent link between hepatitis B and C infections and liver cancer, highlighting the importance of scaling up prevention, treatment, and surveillance to achieve elimination goals. Speakers are sharing critical epidemiological insights, strategic public health interventions to reduce HCC mortality, and lessons learned from real-world sentinel surveillance projects across Europe. A vital session reinforcing the message that tackling viral hepatitis is essential for building a healthier future and preventing liver cancer.

🚨 Just 1 day to go until #WorldLiverDay 2025! 💥 Tomorrow, we come together to celebrate liver health — and at EASL, we're proud to be part of this global initiative alongside @alehlatam, @AASLDtweets @APASLnews and @Solda_Society. This year’s theme, “Food is Medicine,” reminds us that what’s on our plate can protect our livers, prevent and even reverse liver disease. Be part of the conversation. Share the message and tag @WorldLiverDay. 📢 All campaign tools and resources are ready for you at worldliverday.org @SagiZelber @AleksanderKrag @DebbieShawcros1 @josewillemse @JVLazarus @EASLedu @JHepatology #WorldLiverDay #FoodIsMedicine #LiverHealth #Healthydiet #Nutrition #LiverX #LiverTwitter The World Liver Day activities carried out under the umbrella of Healthy Livers, Healthy Lives, are supported by Boehringer Ingelheim, Echosens, MSD, and Novo Nordisk. Our industry partners have had no input into the content of the World Liver Day activities.